Clinical Trial Update: Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports on adherence, efficacy, and tolerability of a once-daily nevirapine-based regimen in HIV-1 infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viramune (Nevirapine)

Snippet

Sponsor: University Hospital, Caen | Conditions: HIV Infections | Phase 4 | Status: COMPLETED